The ngs-based rna-sequencing market size has grown exponentially in recent years. It will grow from $4.2 billion in 2025 to $5.27 billion in 2026 at a compound annual growth rate (CAGR) of 25.3%. The growth in the historic period can be attributed to expansion of genomic research initiatives, declining cost of sequencing technologies, increased use of rna-seq in academic research, availability of advanced sequencing platforms, growth of bioinformatics capabilities.
The ngs-based rna-sequencing market size is expected to see exponential growth in the next few years. It will grow to $12.73 billion in 2030 at a compound annual growth rate (CAGR) of 24.7%. The growth in the forecast period can be attributed to increasing adoption of rna sequencing in clinical diagnostics, rising investments in precision medicine, expansion of pharmaceutical research applications, growing demand for integrated data analysis solutions, increasing focus on multi-omics research. Major trends in the forecast period include increasing adoption of high-throughput rna sequencing platforms, rising demand for single-cell rna sequencing, growing use of cloud-based bioinformatics analysis, expansion of transcriptomics in precision medicine, enhanced focus on data accuracy and scalability.
The expanding pharmaceutical industry is anticipated to support the continued growth of the NGS-based RNA-sequencing market. The pharmaceutical industry encompasses the research, development, and manufacturing of drugs and medicines by both public and private organizations. Within this sector, NGS-based RNA-sequencing is widely used to perform comprehensive gene expression analysis, identify and validate potential drug targets, evaluate drug responses, and gain deeper insights into disease biology, thereby supporting more efficient and data-driven drug discovery and development. For example, in November 2024, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, North America accounted for 54.8% of global pharmaceutical sales in 2024, while Europe represented 22.7%. As a result, the expansion of the pharmaceutical industry is contributing significantly to the growth of the NGS-based RNA-sequencing market.
Leading companies active in the NGS-based RNA-sequencing market are increasingly concentrating on the development of innovative offerings such as advanced small RNA-sequencing kits to simplify workflows and enhance the precision and efficiency of RNA expression studies. These advanced small RNA-seq kits are next-generation library preparation solutions engineered to accurately capture and sequence small RNA molecules, enabling researchers to shorten processing times, reduce technical artifacts such as adapter dimers, and generate more consistent and reproducible expression data. For instance, in October 2025, Lexogen, an Austria-based biotechnology company, introduced the miRVEL Profiling Small RNA-Seq Library Prep Kit, which is designed to streamline and optimize small RNA research workflows. The kit enables the preparation of ready-to-sequence libraries in less than seven hours with limited hands-on time, incorporates advanced adapter-blocking technology to minimize adapter dimer formation, delivers reproducible performance across a wide range of input amounts, and includes integrated 8-nucleotide unique dual indices for accurate multiplexing and read assignment. The miRVEL Profiling Kit supports diverse applications such as RNA interference research, studies of host defense mechanisms, and plant and agricultural small RNA analysis, and is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, offering a comprehensive end-to-end solution for small RNA sequencing.
In November 2024, ARCHIMED SAS, a France-based private equity firm, acquired SeqCenter LLC for an undisclosed consideration. Through this acquisition, ARCHIMED sought to enhance its diagnostics and life-science tools portfolio by expanding SeqCenter’s next-generation sequencing capabilities, accelerating international growth, and promoting innovation in high-throughput and cost-efficient DNA and RNA sequencing services. SeqCenter LLC is a United States-based genetic sequencing services provider specializing in fast, reliable, and affordable DNA and RNA sequencing solutions for use across research, biotechnology, diagnostics, agriculture, and environmental health applications.
Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.
North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ngs-based rna-sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the NGS-based RNA-sequencing market by increasing costs of imported sequencing instruments, reagents, consumables, and data storage infrastructure. Research laboratories and biotechnology companies in North America and Europe are most affected due to dependence on imported platforms, while Asia-Pacific faces cost pressure on sequencing services. These tariffs are increasing operational costs and slowing technology upgrades. However, they are also encouraging domestic instrument manufacturing, regional reagent production, and development of localized sequencing service providers.
The ngs-based rna-sequencing market research report is one of a series of new reports that provides ngs-based rna-sequencing market statistics, including ngs-based rna-sequencing industry global market size, regional shares, competitors with a ngs-based rna-sequencing market share, detailed ngs-based rna-sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the ngs-based rna-sequencing industry. This ngs-based rna-sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
NGS-based RNA-sequencing is a technique employed to identify and quantify the amount of ribonucleic acid (RNA) present in a biological sample at a specific moment, utilizing next-generation sequencing (NGS). Next-generation sequencing, characterized by massively parallel sequencing technology, offers exceptionally high throughput, scalability, and speed, allowing for the determination of nucleotide sequences in whole genomes or specific DNA/RNA segments.
The primary products and services associated with NGS-based RNA sequencing include sample preparation products, sequencing platforms and consumables, sequencing services, and data analysis, storage, & management. Sample preparation products facilitate the adherence of DNA or RNA to the sequencing flowcell, enabling sample identification. The sample preparation process involves converting nucleic acid mixtures from biological samples into various libraries, preparing them for NGS technologies. Technologies involved in NGS encompass sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. These sequencing methods find application in expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, variant calling, and transcriptome epigenetics. NGS-based RNA-sequencing is utilized by a range of end users, including research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other entities in the scientific community.
The NGS-based RNA-sequencing market includes revenues earned by ribosomal RNA (rRNA), transfer RNA (tRNA), long ncRNA and many smaller ncRNAs such as microRNA. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ngs-based rna-sequencing market size is expected to see exponential growth in the next few years. It will grow to $12.73 billion in 2030 at a compound annual growth rate (CAGR) of 24.7%. The growth in the forecast period can be attributed to increasing adoption of rna sequencing in clinical diagnostics, rising investments in precision medicine, expansion of pharmaceutical research applications, growing demand for integrated data analysis solutions, increasing focus on multi-omics research. Major trends in the forecast period include increasing adoption of high-throughput rna sequencing platforms, rising demand for single-cell rna sequencing, growing use of cloud-based bioinformatics analysis, expansion of transcriptomics in precision medicine, enhanced focus on data accuracy and scalability.
The expanding pharmaceutical industry is anticipated to support the continued growth of the NGS-based RNA-sequencing market. The pharmaceutical industry encompasses the research, development, and manufacturing of drugs and medicines by both public and private organizations. Within this sector, NGS-based RNA-sequencing is widely used to perform comprehensive gene expression analysis, identify and validate potential drug targets, evaluate drug responses, and gain deeper insights into disease biology, thereby supporting more efficient and data-driven drug discovery and development. For example, in November 2024, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, North America accounted for 54.8% of global pharmaceutical sales in 2024, while Europe represented 22.7%. As a result, the expansion of the pharmaceutical industry is contributing significantly to the growth of the NGS-based RNA-sequencing market.
Leading companies active in the NGS-based RNA-sequencing market are increasingly concentrating on the development of innovative offerings such as advanced small RNA-sequencing kits to simplify workflows and enhance the precision and efficiency of RNA expression studies. These advanced small RNA-seq kits are next-generation library preparation solutions engineered to accurately capture and sequence small RNA molecules, enabling researchers to shorten processing times, reduce technical artifacts such as adapter dimers, and generate more consistent and reproducible expression data. For instance, in October 2025, Lexogen, an Austria-based biotechnology company, introduced the miRVEL Profiling Small RNA-Seq Library Prep Kit, which is designed to streamline and optimize small RNA research workflows. The kit enables the preparation of ready-to-sequence libraries in less than seven hours with limited hands-on time, incorporates advanced adapter-blocking technology to minimize adapter dimer formation, delivers reproducible performance across a wide range of input amounts, and includes integrated 8-nucleotide unique dual indices for accurate multiplexing and read assignment. The miRVEL Profiling Kit supports diverse applications such as RNA interference research, studies of host defense mechanisms, and plant and agricultural small RNA analysis, and is compatible with Lexogen’s SPLIT RNA extraction kits and TraPR small RNA enrichment system, offering a comprehensive end-to-end solution for small RNA sequencing.
In November 2024, ARCHIMED SAS, a France-based private equity firm, acquired SeqCenter LLC for an undisclosed consideration. Through this acquisition, ARCHIMED sought to enhance its diagnostics and life-science tools portfolio by expanding SeqCenter’s next-generation sequencing capabilities, accelerating international growth, and promoting innovation in high-throughput and cost-efficient DNA and RNA sequencing services. SeqCenter LLC is a United States-based genetic sequencing services provider specializing in fast, reliable, and affordable DNA and RNA sequencing solutions for use across research, biotechnology, diagnostics, agriculture, and environmental health applications.
Major companies operating in the ngs-based rna-sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, QIAGEN N.V., Eurofins Scientific SE, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ Inc., Novogene Corporation, Macrogen Inc., Zymo Research Corp., Lexogen GmbH, Partek Incorporated, GATC Biotech AG, Genohub LLC, BaseClear B.V., Otogenetics Corporation, SeqLL LLC, GenXPro GmbH, Genotypic Technology Pvt. Ltd.
North America was the largest region in the NGS-based RNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ngs-based rna-sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ngs-based rna-sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the NGS-based RNA-sequencing market by increasing costs of imported sequencing instruments, reagents, consumables, and data storage infrastructure. Research laboratories and biotechnology companies in North America and Europe are most affected due to dependence on imported platforms, while Asia-Pacific faces cost pressure on sequencing services. These tariffs are increasing operational costs and slowing technology upgrades. However, they are also encouraging domestic instrument manufacturing, regional reagent production, and development of localized sequencing service providers.
The ngs-based rna-sequencing market research report is one of a series of new reports that provides ngs-based rna-sequencing market statistics, including ngs-based rna-sequencing industry global market size, regional shares, competitors with a ngs-based rna-sequencing market share, detailed ngs-based rna-sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the ngs-based rna-sequencing industry. This ngs-based rna-sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
NGS-based RNA-sequencing is a technique employed to identify and quantify the amount of ribonucleic acid (RNA) present in a biological sample at a specific moment, utilizing next-generation sequencing (NGS). Next-generation sequencing, characterized by massively parallel sequencing technology, offers exceptionally high throughput, scalability, and speed, allowing for the determination of nucleotide sequences in whole genomes or specific DNA/RNA segments.
The primary products and services associated with NGS-based RNA sequencing include sample preparation products, sequencing platforms and consumables, sequencing services, and data analysis, storage, & management. Sample preparation products facilitate the adherence of DNA or RNA to the sequencing flowcell, enabling sample identification. The sample preparation process involves converting nucleic acid mixtures from biological samples into various libraries, preparing them for NGS technologies. Technologies involved in NGS encompass sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. These sequencing methods find application in expression profiling analysis, small RNA sequencing, de novo transcriptome assembly, variant calling, and transcriptome epigenetics. NGS-based RNA-sequencing is utilized by a range of end users, including research & academia, hospitals & clinics, pharmaceutical & biotechnology companies, and other entities in the scientific community.
The NGS-based RNA-sequencing market includes revenues earned by ribosomal RNA (rRNA), transfer RNA (tRNA), long ncRNA and many smaller ncRNAs such as microRNA. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. NGS-Based RNA-Sequencing Market Characteristics
3. NGS-Based RNA-Sequencing Market Supply Chain Analysis
4. Global NGS-Based RNA-Sequencing Market Trends and Strategies
5. NGS-Based RNA-Sequencing Market Analysis of End Use Industries
7. Global NGS-Based RNA-Sequencing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global NGS-Based RNA-Sequencing Total Addressable Market (TAM) Analysis for the Market
9. NGS-Based RNA-Sequencing Market Segmentation
10. NGS-Based RNA-Sequencing Market Regional and Country Analysis
11. Asia-Pacific NGS-Based RNA-Sequencing Market
12. China NGS-Based RNA-Sequencing Market
13. India NGS-Based RNA-Sequencing Market
14. Japan NGS-Based RNA-Sequencing Market
15. Australia NGS-Based RNA-Sequencing Market
16. Indonesia NGS-Based RNA-Sequencing Market
17. South Korea NGS-Based RNA-Sequencing Market
18. Taiwan NGS-Based RNA-Sequencing Market
19. South East Asia NGS-Based RNA-Sequencing Market
20. Western Europe NGS-Based RNA-Sequencing Market
21. UK NGS-Based RNA-Sequencing Market
22. Germany NGS-Based RNA-Sequencing Market
23. France NGS-Based RNA-Sequencing Market
24. Italy NGS-Based RNA-Sequencing Market
25. Spain NGS-Based RNA-Sequencing Market
26. Eastern Europe NGS-Based RNA-Sequencing Market
27. Russia NGS-Based RNA-Sequencing Market
28. North America NGS-Based RNA-Sequencing Market
29. USA NGS-Based RNA-Sequencing Market
30. Canada NGS-Based RNA-Sequencing Market
31. South America NGS-Based RNA-Sequencing Market
32. Brazil NGS-Based RNA-Sequencing Market
33. Middle East NGS-Based RNA-Sequencing Market
34. Africa NGS-Based RNA-Sequencing Market
36. NGS-Based RNA-Sequencing Market Competitive Landscape and Company Profiles
37. NGS-Based RNA-Sequencing Market Other Major and Innovative Companies
40. NGS-Based RNA-Sequencing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
NGS-Based RNA-Sequencing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ngs-based rna-sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ngs-based rna-sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ngs-based rna-sequencing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product And Service: Sample Preparation Products; Sequencing Platforms and Consumables; Sequencing Services; Data Analysis, Storage, and Management2) By Technology: Sequencing by Synthesis; Ion Semiconductor Sequencing; Single-molecule Real-time Sequencing; Nanopore Sequencing
3) By Application: Expression Profiling Analysis; Small RNA Sequencing; De Novo Transcriptome Assembly
4) By End User: Research & Academia; Pharmaceutical & Biotechnology Companies; Other End Users
Subsegments:
1) By Sample Preparation Products: RNA Extraction Kits; Library Preparation Kits; Reverse Transcription Kits; Quality Control Reagents2) By Sequencing Platforms And Consumables: Sequencing Instruments; Sequencing Consumables
3) By Sequencing Services: Contract Sequencing Services; Custom Library Preparation Services; Consultation And Experimental Design Services
4) By Data Analysis, Storage, And Management: Bioinformatics Software; Data Analysis Services; Cloud-Based Data Storage Solutions; Data Management Platforms
Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Oxford Nanopore Technologies Ltd.; Agilent Technologies Inc.; BGI Group; QIAGEN N.V.; Eurofins Scientific SE; Bio-Rad Laboratories Inc.; F. Hoffmann-La Roche Ltd.; Takara Bio Inc.; GENEWIZ Inc.; Novogene Corporation; Macrogen Inc.; Zymo Research Corp.; Lexogen GmbH; Partek Incorporated; GATC Biotech AG; Genohub LLC; BaseClear B.V.; Otogenetics Corporation; SeqLL LLC; GenXPro GmbH; Genotypic Technology Pvt. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this NGS-Based RNA-Sequencing market report include:- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Oxford Nanopore Technologies Ltd.
- Agilent Technologies Inc.
- BGI Group
- QIAGEN N.V.
- Eurofins Scientific SE
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Takara Bio Inc.
- GENEWIZ Inc.
- Novogene Corporation
- Macrogen Inc.
- Zymo Research Corp.
- Lexogen GmbH
- Partek Incorporated
- GATC Biotech AG
- Genohub LLC
- BaseClear B.V.
- Otogenetics Corporation
- SeqLL LLC
- GenXPro GmbH
- Genotypic Technology Pvt. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.27 Billion |
| Forecasted Market Value ( USD | $ 12.73 Billion |
| Compound Annual Growth Rate | 24.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
